Spike in Warning Letters Sends Tremors Through Industry

By CenterWatch
Published: August 2011

The number of warning letters is increasing as the FDA ramps up enforcement efforts. The FDA is focusing more attention on data integrity and on the accountability of CROs in functional and strategic alliances.

To learn more register for our free white paper Spike in Warning Letters Sends Tremors Through Industry.

Please enter in your information below. Fields with an * are required.

Please enter a valid email address to receive an email with a link to download the white paper.   

Please check the types of email communications you would like to receive:

CenterWatch offers a range of white papers for download that investigate and analyze current trends in the clinical trials industry and the impact they have on the research community.

Recent titles from CenterWatch:

Mobile health picks up momentum

Lack of clinical data overshadows opioid prescribing guidelines

CROs begin consolidating site landscape